Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

720 ARTÍCULOS , VIENDO DEL 166 AL 180

Natural Antioxidants: An Effective Strategy for the Treatment of Alzheimer's Disease at the Early Stage

Wang Y, Huang Y, Ma A, You J, Miao J, Li J.

J Agric Food Chem. 2024 May 29;72(21):11854-11870. doi: 10.1021/acs.jafc.4c01323. Epub 2024 May 14.

The impact of chelating compounds on Cu(2+), Fe(2+)/(3+), and Zn(2+) ions in Alzheimer's disease treatment

Mazur T, Malik M, Bieńko DC.

J Inorg Biochem. 2024 Aug;257:112601. doi: 10.1016/j.jinorgbio.2024.112601. Epub 2024 May 9.

Short-chain fatty acids: Important components of the gut-brain axis against AD

Huang Y, Wang YF, Miao J, Zheng RF, Li JY.

Biomed Pharmacother. 2024 Jun;175:116601. doi: 10.1016/j.biopha.2024.116601. Epub 2024 May 14.

Pharmacologic and Nutritional Interventions for Early Alzheimer's Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Zeng B, Tang C, Wang J, Yang Q, Ren Q, Liu X.

J Alzheimers Dis. 2024;99(4):1173-1186. doi: 10.3233/JAD-240161.

Navigating the Maze of Alzheimer's disease by exploring BACE1: Discovery, current scenario, and future prospects

Iram F, Shahid M, Ansari J, Ashraf GM, Hassan MI, Islam A.

Ageing Res Rev. 2024 Jul;98:102342. doi: 10.1016/j.arr.2024.102342. Epub 2024 May 16.

Exploring Curcumin-Loaded Lipid-Based Nanomedicine as Efficient Targeted Therapy for Alzheimer's Diseases

Far BF, Safaei M, Pourmolaei A, Adibamini S, Shirdel S, Shirdel S, Emadi R, Kaushik AK.

ACS Appl Bio Mater. 2024 Jun 17;7(6):3535-3555. doi: 10.1021/acsabm.4c00112. Epub 2024 May 20.

Pericytes in Alzheimer's disease: Key players and therapeutic targets

Zhang Y, Mu BR, Ran Z, Zhu T, Huang X, Yang X, Wang DM, Ma QH, Lu MH.

Exp Neurol. 2024 Sep;379:114825. doi: 10.1016/j.expneurol.2024.114825. Epub 2024 May 21.

Bio-Nano Toolbox for Precision Alzheimer's Disease Gene Therapy

Liu Y, Xia X, Zheng M, Shi B.

Adv Mater. 2024 Jul;36(29):e2314354. doi: 10.1002/adma.202314354. Epub 2024 May 22.

A potential new treatment for Alzheimer's disease … and other research

Nolan T.

BMJ. 2024 May 23;385:q1125. doi: 10.1136/bmj.q1125.

The donepezil transdermal system for the treatment of patients with mild, moderate, or severe Alzheimer's disease: a critical review

Buck A, Rezaei K, Quazi A, Goldmeier G, Silverglate B, Grossberg GT.

Expert Rev Neurother. 2024 Jun;24(6):607-614. doi: 10.1080/14737175.2024.2355981. Epub 2024 May 24.

Ferroptosis: A new strategy for targeting Alzheimer's disease

Qiang RR, Xiang Y, Zhang L, Bai XY, Zhang D, Li YJ, Yang YL, Liu XL.

Neurochem Int. 2024 Sep;178:105773. doi: 10.1016/j.neuint.2024.105773. Epub 2024 May 23.

Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer's Disease

Rebassa JB, Capó T, Lillo J, Raïch I, Reyes-Resina I, Navarro G.

Int J Mol Sci. 2024 May 15;25(10):5378. doi: 10.3390/ijms25105378.

Decoding the role of the CCL2/CCR2 axis in Alzheimer's disease and innovating therapeutic approaches: Keeping All options open

Arfaei R, Mikaeili N, Daj F, Boroumand A, Kheyri A, Yaraghi P, Shirzad Z, Keshavarz M, Hassanshahi G, Jafarzadeh A, Shahrokhi VM, Khorramdelazad H.

Int Immunopharmacol. 2024 Jun 30;135:112328. doi: 10.1016/j.intimp.2024.112328. Epub 2024 May 25.

Regulation of mitochondrial dysfunction by estrogens and estrogen receptors in Alzheimer's disease: A focused review

Arjmand S, Ilaghi M, Sisakht AK, Guldager MB, Wegener G, Landau AM, Gjedde A.

Basic Clin Pharmacol Toxicol. 2024 Aug;135(2):115-132. doi: 10.1111/bcpt.14035. Epub 2024 May 27.

Inhibiting the Aggregation of Aβ by Natural Product Molecules

Bai SC, Wang YC, Li XZ, Li G.

ChemMedChem. 2024 Sep 2;19(17):e202400223. doi: 10.1002/cmdc.202400223. Epub 2024 Jul 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias